Cryo-Cell International

About

We were incorporated in 1989 and have been involved in the umbilical cord blood preservation business since 1992—achieving a number of successful cord blood transplants for diseases including leukemia, anemia and lymphoma. In 2004, we relocated to our new state-of-the-art processing lab and cryogenic storage facility in Oldsmar, Florida, which is cGMP/cGTP-compliant.

Cryo-Cell is a global leader in stem cell innovation. We discovered and launched the ground-breaking Célle menstrual stem cell technology. We deliver the highest accredited standard of quality and superior overall value, customer service that’s here for you, 24 hours a day, 7 days a week. Cryo-Cell is on the forefront of medical research and development with globally-renowned Célle research partnerships, including part-ownership of biomedical research firm Saneron CCEL Therapeutics, Inc.

We employ only qualified personnel, and use the best and most advanced equipment and processes available in processing, testing and preserving your baby’s cord blood stem cells. And only Cryo-Cell’s U-Cord® service is overseen by our impressive Medical & Scientific Advisory Board.

Cryo-Cell is a stable, successful and profitable corporation. We are a publicly traded company (OTC BB: Symbol CCEL). If you’d like more financial information, it is available on the Internet and filed with the SEC.